Antineoplastic Effects of Ankaferd Hemostat.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2022
Historique:
received: 01 06 2022
accepted: 21 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 16 8 2022
Statut: epublish

Résumé

Up to June 2022, literature searches were performed using the internet search engines Medline, Google Scholar, and Embase: Ankaferd. PRISMA flow diagram described the Ankaferd search. ABS have important effects in several cellular processes, like control of the cell cycle, apoptosis, angiogenesis, signal transduction, inflammation, immunologic, and metabolic mechanisms. The molecular basis of antineoplastic roles of ABS depends on its proteomics, metabolomics, and transcriptomics features. ABS has antineoplastic effects on solid tumors like colon, bladder, breast, and osteosarcoma cancer cells. Also, ABS effects renal tubular apoptosis and has antitumoral roles on malign melanoma cells. ABS inhibits hematological tumors like myeloma and lymphoid cells. ABS induces apoptosis in retinal cells and has inhibitory effects on mesenchymal stem cells. It has an antiproliferative role on gastrointestinal tumors like hepatocellular carcinoma cells. Moreover, ABS has a treatment supportive role in cancer since it can prevent oxidative DNA damage and decrease the intestinal damage in necrotizing enterocolitis. Furthermore, it has chemopreventive and hepatoprotective features and can be used for prophylaxis and treatment of oral mucositis. ABS alters cell metabolism and cell cycle. ABS has antineoplastic role on cancer cells. The expanding context of ABS compromises anti-infective, antineoplastic, and wound healing features. ABS may also be used for the palliative, adjuvant, neoadjuvant, or supportive use by interventional radiology procedures for the treatment of solid tumors. Future controlled studies are necessary to clarify the pleiotropic role of ABS like antineoplastic, antithrombotic, anti-inflammatory, anti-infective, antifungal, and antioxidative effects.

Identifiants

pubmed: 35958818
doi: 10.1155/2022/2665903
pmc: PMC9363200
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antineoplastic Agents 0
Hemostatics 0
Plant Extracts 0
ankaferd blood stopper 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2665903

Informations de copyright

Copyright © 2022 Umit Yavuz Malkan and Ibrahim Celalettin Haznedaroglu.

Déclaration de conflit d'intérêts

The authors declare that there is no conflicts of interest regarding the publication of this article.

Références

Clin Appl Thromb Hemost. 2012 Nov;18(6):604-10
pubmed: 22327821
Turk J Haematol. 2018 Mar 1;35(1):85-86
pubmed: 29391340
Turk J Haematol. 2010 Jun 5;27(2):70-7
pubmed: 27263447
Photochem Photobiol Sci. 2012 Jan;11(1):90-7
pubmed: 21804977
Turk J Med Sci. 2021 Jun 27;:
pubmed: 34174802
Blood Coagul Fibrinolysis. 2015 Mar;26(2):233-4
pubmed: 25629421
Int J Clin Exp Pathol. 2015 May 01;8(5):5387-94
pubmed: 26191241
Chin J Cancer. 2012 Nov;31(11):519-31
pubmed: 23114090
Saudi Med J. 2010 Aug;31(8):864-8
pubmed: 20714682
Oncogene. 2004 Jul 8;23(31):5409-14
pubmed: 15107819
Turk J Med Sci. 2020 Apr 14;50(SI-2):1739-1750
pubmed: 32283900
Pharmacol Rev. 2001 Jun;53(2):245-82
pubmed: 11356985
Turk J Med Sci. 2020 Sep 27;51(3):1472-1480
pubmed: 32979898
Tumour Biol. 2015 Aug;36(8):6211-21
pubmed: 25753478
Mol Cancer Ther. 2009 Jun;8(6):1460-72
pubmed: 19509251
SAGE Open Med. 2017 Feb 10;5:2050312116689519
pubmed: 28293423
P T. 2012 Sep;37(9):503-30
pubmed: 23066344
Turk J Med Sci. 2016 Apr 19;46(3):657-63
pubmed: 27513238
J Biol Chem. 1994 Oct 21;269(42):26486-91
pubmed: 7929370
Altern Med Rev. 2010 Dec;15(4):329-36
pubmed: 21194248
Int J Clin Pract. 2021 Nov;75(11):e14789
pubmed: 34480836
Int J Pediatr Otorhinolaryngol. 2014 Dec;78(12):2222-8
pubmed: 25458164
Biomed Pharmacother. 2019 Feb;110:105-110
pubmed: 30465999
Cell Cycle. 2012 Oct 15;11(20):3887-95
pubmed: 22983008
Biomed Res Int. 2019 May 21;2019:5268031
pubmed: 31240215
Int Immunopharmacol. 2006 Mar;6(3):494-8
pubmed: 16428085
FEBS Lett. 2012 Jan 20;586(2):122-6
pubmed: 22210188
Cancer Res. 2012 Jan 1;72(1):165-75
pubmed: 22080569
Hum Exp Toxicol. 2012 Aug;31(8):780-7
pubmed: 22297699
Turk J Haematol. 2011 Dec 5;28(4):276-85
pubmed: 27264584
Crit Rev Oncol Hematol. 2012 Jul;83(1):21-34
pubmed: 22079213
Biomed Res Int. 2016;2016:8957820
pubmed: 26925418
SAGE Open Med. 2020 Feb 16;8:2050312120907811
pubmed: 32110403
Annu Rev Med. 2015;66:311-28
pubmed: 25587654
Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E165-70
pubmed: 21406410
Free Radic Biol Med. 2015 Oct;87:193-203
pubmed: 26119785
Gene Expr. 2015;16(3):101-8
pubmed: 25700366
Gastroenterology Res. 2009 Oct;2(5):295-302
pubmed: 27956974
Clin Oral Investig. 2018 Dec;22(9):3091-3096
pubmed: 29500540
Turk J Med Sci. 2021 Nov 13;51(6):3136-3137
pubmed: 34773687
Cryobiology. 2014 Jun;68(3):405-10
pubmed: 24662029
Neoplasia. 2008 Apr;10(4):340-7
pubmed: 18392135

Auteurs

Umit Yavuz Malkan (UY)

Hacettepe University, Faculty of Medicine, Department of Hematology, Ankara, Turkey.

Ibrahim Celalettin Haznedaroglu (IC)

Hacettepe University, Faculty of Medicine, Department of Hematology, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH